Microfluidic Chip for Leukocyte Adhesion Cascade Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro models fail to comprehensively study the leukocyte adhesion cascade, specifically rolling, adhesion, and migration, due to limitations in simulating physiological shear and real-time visualization, which hampers the understanding and development of anti-inflammatory drugs.
Innovation Solution
A microfluidic chip with optically clear, plastic flow channels coated with endothelial cells and featuring synthetic microvascular networks that allow for real-time visualization and quantitative measurement of leukocyte migration, enabling direct assessment of the leukocyte adhesion cascade steps, including rolling, firm arrest, and extravasation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If flow chambers are used to study rolling and adhesion phenomena, then physiological shear is provided, but transmigration cannot be modeled
Solution Approach 1:
The patent combines multiple functions (rolling, adhesion, and transmigration studies) into a single microfluidic device. The device integrates flow channels with endothelial cell coatings for rolling/adhesion studies and porous membranes for transmigration studies, allowing all three phenomena to be studied in one experimental system rather than requiring separate chambers for each function.
Solution Approach 2:
The microfluidic device is designed as a universal platform that can perform multiple assays simultaneously. It includes regions for studying leukocyte rolling on endothelial cells, firm adhesion events, and transmigration through porous membranes, all within a single device that maintains physiological shear conditions across all regions.
2Measurement precision
If Transwell and Boyden chambers are used for migration studies, then migration can be measured, but fluid shear and real-time visualization are not provided
Solution Approach 1:
The patent replaces the static mechanical structure of Transwell/Boyden chambers with a dynamic microfluidic system. The microfluidic device incorporates flow channels that generate physiological shear stress and allows real-time visualization of cell migration through transparent components and microscopy integration, while maintaining the migration measurement capability through porous membrane structures.
Solution Approach 2:
The patent introduces porous membranes as an intermediary structure that enables migration measurement while allowing fluid flow and shear stress application. These porous membranes serve as the transition zone where leukocytes can migrate from the flow channel into the lower chamber, providing both migration quantification capability and physiological flow conditions.
3Difficulty of detecting and measuring
If current in vitro models are used, then specific aspects of leukocyte adhesion cascade can be studied, but comprehensive understanding is limited
Solution Approach 1:
The patent segments the leukocyte adhesion cascade into distinct functional regions within the microfluidic device: a flow channel region for rolling and adhesion studies with endothelial cell coatings, and a transmigration region with porous membranes. This segmentation allows each aspect to be studied with optimized conditions while maintaining the ability to observe the complete cascade sequence.
Solution Approach 2:
The patent implements a nested structure where the porous membrane is embedded within the microfluidic device architecture. The membrane is positioned such that flow channels are formed above it, creating a nested configuration where the migration substrate is integrated within the flow system, allowing simultaneous observation of rolling, adhesion, and transmigration events.
Data Source
AI summary
An apparatus and method for identifying and screening for agents affecting the leukocyte adhesion cascade (LAC) encompassing rolling, adhesion and migration comprises an optically clear, plastic microfluidic chip comprising flow channels with diameters in the range of 10-500 μm. The flow channels are coated with endothelial cells and at least a portion of the flow channels contains 1-30 μm sized openings, optionally filled with a native or synthetic extracellular matrix, that allow leukocyte migration into one or more tissue spaces.